{"id":"https://openalex.org/W1998765648","doi":"https://doi.org/10.1016/j.jalz.2011.05.2250","title":"P4\u2010225: A confirmatory phase 3 randomized, double\u2010blind, placebo\u2010controlled study of the safety and effectiveness of immune globulin intravenous (Human), 10% solution (GAMMAGARD LIQUID/KIOVIG) for the treatment of mild to moderate Alzheimer's disease","display_name":"P4\u2010225: A confirmatory phase 3 randomized, double\u2010blind, placebo\u2010controlled study of the safety and effectiveness of immune globulin intravenous (Human), 10% solution (GAMMAGARD LIQUID/KIOVIG) for the treatment of mild to moderate Alzheimer's disease","publication_year":2011,"publication_date":"2011-07-01","ids":{"openalex":"https://openalex.org/W1998765648","doi":"https://doi.org/10.1016/j.jalz.2011.05.2250","mag":"1998765648"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2011.05.2250","doi":"https://doi.org/10.1016/j.jalz.2011.05.2250","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2011.05.2250","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059408905","display_name":"Deborah A. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99484792","display_name":"Baxter (United States)","ror":"https://ror.org/02d6ew870","country_code":"US","type":"company","lineage":["https://openalex.org/I99484792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah A. Lee","raw_affiliation_strings":["Baxter Healthcare Corp Westlake Village California United States","Baxter Healthcare Corp, Westlake Village, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baxter Healthcare Corp Westlake Village California United States","institution_ids":["https://openalex.org/I99484792"]},{"raw_affiliation_string":"Baxter Healthcare Corp, Westlake Village, California, United States","institution_ids":["https://openalex.org/I99484792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040652962","display_name":"Leock Y. Ngo","orcid":"https://orcid.org/0000-0002-8184-1367","observed_orcids":["https://orcid.org/0000-0002-8184-1367"]},"institutions":[{"id":"https://openalex.org/I99484792","display_name":"Baxter (United States)","ror":"https://ror.org/02d6ew870","country_code":"US","type":"company","lineage":["https://openalex.org/I99484792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leock Y Ngo","raw_affiliation_strings":["Baxter Healthcare Corp Westlake Village California United States","Baxter Healthcare Corp, Westlake Village, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baxter Healthcare Corp Westlake Village California United States","institution_ids":["https://openalex.org/I99484792"]},{"raw_affiliation_string":"Baxter Healthcare Corp, Westlake Village, California, United States","institution_ids":["https://openalex.org/I99484792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078762489","display_name":"Basia Adamiak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99484792","display_name":"Baxter (United States)","ror":"https://ror.org/02d6ew870","country_code":"US","type":"company","lineage":["https://openalex.org/I99484792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Basia Adamiak","raw_affiliation_strings":["Baxter Healthcare Corp Westlake Village California United States","Baxter Healthcare Corp, Westlake Village, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baxter Healthcare Corp Westlake Village California United States","institution_ids":["https://openalex.org/I99484792"]},{"raw_affiliation_string":"Baxter Healthcare Corp, Westlake Village, California, United States","institution_ids":["https://openalex.org/I99484792"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009789236","display_name":"David M. Gelmont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99484792","display_name":"Baxter (United States)","ror":"https://ror.org/02d6ew870","country_code":"US","type":"company","lineage":["https://openalex.org/I99484792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Gelmont","raw_affiliation_strings":["Baxter Healthcare Corp Westlake Village California United States","Baxter Healthcare Corp, Westlake Village, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baxter Healthcare Corp Westlake Village California United States","institution_ids":["https://openalex.org/I99484792"]},{"raw_affiliation_string":"Baxter Healthcare Corp, Westlake Village, California, United States","institution_ids":["https://openalex.org/I99484792"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I99484792"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.13666964,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"4S_Part_22","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.09200000017881393,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9639999866485596},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9380000233650208}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7972737550735474},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6506428718566895},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5386990904808044},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5288613438606262},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4834490716457367},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4834076464176178},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.47003883123397827},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.46156612038612366},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.40918850898742676},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1640312373638153},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2011.05.2250","doi":"https://doi.org/10.1016/j.jalz.2011.05.2250","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2011.05.2250","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2297790284","https://openalex.org/W1852785632","https://openalex.org/W2920703862","https://openalex.org/W4299891181","https://openalex.org/W2967889405","https://openalex.org/W1919236762","https://openalex.org/W2142836028","https://openalex.org/W4288061592","https://openalex.org/W3080304190","https://openalex.org/W1034014085"],"abstract_inverted_index":{"Intravenous":[0],"immunoglobulin":[1,257],"(IVIg)":[2],"has":[3,50],"demonstrated":[4,32,254],"promising":[5],"results":[6,210],"in":[7,17,47,53,82,91,105,116,195,243,261,273,283,304],"the":[8,92,129,202,205,212,230,238,244,262],"treatment":[9,239,263],"of":[10,63,77,102,128,174,198,204,211,218,232,264,276],"mild":[11,85,106,265],"to":[12,26,56,86,107,112,124,183,266,280,302],"moderate":[13,87,108,267],"Alzheimer's":[14],"disease":[15],"(AD)":[16],"Phase":[18,21,74,99,214,248,286],"1":[19,249],"and":[20,39,65,95,159,166,176,222,250,297],"2":[22,130,149,251],"trials.":[23],"When":[24],"compared":[25],"placebo,":[27],"subjects":[28,83,120,277],"treated":[29],"with":[30,59,84,161,291],"IVIg":[31,45],"improved":[33],"cognitive":[34],"performance,":[35],"better":[36],"global":[37],"functioning,":[38],"less":[40],"brain":[41],"atrophy.":[42],"In":[43,188],"addition,":[44,189],"use":[46],"clinical":[48],"practice":[49],"been":[51],"shown":[52],"retrospective":[54],"analyses":[55],"be":[57,113,122,193,227,281],"associated":[58],"a":[60,70,196,298],"lower":[61],"incidence":[62],"AD":[64,88,109],"related":[66],"disorders.":[67],"At":[68],"present,":[69],"double-bind,":[71],"placebo-controlled,":[72],"parallel-group":[73],"3":[75,100,215,287],"trial":[76,101],"gammagard":[78,103],"liquid/kiovig":[79,104],"(GAP":[80],"study)":[81],"is":[89,110,294,300],"ongoing":[90,213,296],"United":[93],"States":[94],"Canada.":[96],"A":[97],"confirmatory":[98,234],"planned":[111,301],"initiated":[114],"globally":[115],"2011.":[117,305],"Approximately":[118],"400":[119],"will":[121,156,171,192,278],"randomized":[123],"receive":[125],"either":[126],"one":[127],"active":[131],"dose":[132],"arms":[133],"(0.2":[134],"g/kg":[135,141],"body":[136],"weight":[137],"[BW]":[138],"or":[139,143],"0.4":[140],"BW)":[142],"placebo":[144],"at":[145],"matching":[146],"volume":[147],"every":[148],"weeks":[150],"for":[151,237],"18":[152],"months.":[153],"Primary":[154],"endpoints":[155,163,170],"include":[157,172],"ADAS-Cog":[158],"ADCS-ADL":[160],"secondary":[162],"ADCS-CGIC,":[164],"NPI,":[165],"volumetric":[167],"MRI.":[168],"Exploratory":[169],"quality":[173],"life":[175],"pharmacoeconomic":[177],"measures":[178],"as":[179,181],"well":[180],"time":[182],"skilled":[184],"nursing":[185],"facility":[186],"placement.":[187],"amyloid":[190],"imaging":[191,206],"studied":[194],"subset":[197],"subjects,":[199],"depending":[200],"on":[201,209],"availability":[203],"agent.":[207],"Based":[208],"GAP":[216,245],"study":[217,223,235,290],"IVIg,":[219],"sample":[220],"size":[221,241],"duration":[224],"adjustments":[225],"may":[226,258],"made":[228],"during":[229],"course":[231],"this":[233],"accounting":[236],"effect":[240],"observed":[242],"study.":[246],"Early":[247],"studies":[252],"have":[253,259],"that":[255],"human":[256],"potential":[260],"AD.":[268],"However,":[269],"these":[270],"preliminary":[271],"findings":[272],"small":[274],"groups":[275],"need":[279],"confirmed":[282],"large-scale,":[284],"multi-center":[285],"studies.":[288],"One":[289],"Gammagard":[292],"Liquid/Kiovig":[293],"currently":[295],"second":[299],"begin":[303]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}